(Q34219516)

31 July 2017

0 references

Cochrane review on 'Statins for the treatment of dementia'. (English)

1 reference

31 July 2017

Bernadette McGuinness

1

object named as

Bernadette McGuinness

1 reference

31 July 2017

John O'Hare

2

1 reference

31 July 2017

David Craig

3

1 reference

31 July 2017

Roger Bullock

4

1 reference

31 July 2017

Reem Malouf

5

1 reference

31 July 2017

Peter Passmore

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

2 April 2012

1 reference

International Journal of Geriatric Psychiatry

31 July 2017

1 reference

31 July 2017

28

1 reference

31 July 2017

2

1 reference

31 July 2017

119-126

1 reference

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

31 July 2017

1 reference

Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques

21 January 2018

1 reference

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

The Alzheimer's disease beta-secretase enzyme, BACE1.

21 January 2018

1 reference

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

Paraoxonase 1 activity: a new vascular marker of dementia?

21 January 2018

1 reference

Cholesterol metabolism in the brain

21 January 2018

1 reference

Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts

21 January 2018

1 reference

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

21 January 2018

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain.

21 January 2018

1 reference

Cognitive impairment associated with atorvastatin and simvastatin

21 January 2018

1 reference

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease

21 January 2018

1 reference

Isoprenoids as mediators of the biological effects of statins

21 January 2018

1 reference

Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease

21 January 2018

1 reference

Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis.

21 January 2018

1 reference

High-density lipoprotein cholesterol in differential diagnosis of senile dementia.

21 January 2018

1 reference

Effects of lovastatin on cognitive function and psychological well-being

21 January 2018

1 reference

Serum cholesterol and intellectual performance.

21 January 2018

1 reference

Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.

21 January 2018

1 reference

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment.

21 January 2018

1 reference

Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia

21 January 2018

1 reference

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease

21 January 2018

1 reference

Relation of plasma lipids to Alzheimer disease and vascular dementia

21 January 2018

1 reference

Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies

21 January 2018

1 reference

Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations

21 January 2018

1 reference

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.

21 January 2018

1 reference

Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease

21 January 2018

1 reference

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol.

21 January 2018

1 reference

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

21 January 2018

1 reference

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

Alzheimer's disease beyond APOE.

21 January 2018

1 reference

Association between high-density lipoprotein and cognitive impairment in the oldest old.

21 January 2018

1 reference

Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes

21 January 2018

1 reference

Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments

21 January 2018

1 reference

Statin-associated memory loss: analysis of 60 case reports and review of the literature

21 January 2018

1 reference

Subchronic toxicity of atorvastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor, in beagle dogs.

21 January 2018

1 reference

Is Alzheimer's disease an apolipoprotein E amyloidosis?

21 January 2018

1 reference

A fluid connection: cholesterol and Abeta

21 January 2018

1 reference

Brain region-dependent increases in beta-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits

21 January 2018

1 reference

Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease

21 January 2018

1 reference

Cholesterol-dependent Generation of a Seeding Amyloid β-Protein in Cell Culture

21 January 2018

1 reference

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.

21 January 2018

1 reference

7 January 2021

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study

1 reference

7 January 2021

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

1 reference

7 January 2021

New possible role of statins in age-related diseases

1 reference

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

7 January 2021

Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.

1 reference

7 January 2021

Cholesterol and Alzheimer's disease: is there a link?

1 reference

7 January 2021

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

7 January 2021

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

1 reference

7 January 2021

Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials.

1 reference

7 January 2021

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

1 reference

7 January 2021

Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.3797

1 reference

31 July 2017

1 reference